-
公开(公告)号:US07399862B2
公开(公告)日:2008-07-15
申请号:US11266881
申请日:2005-11-04
申请人: Seok-Ki Choi , Paul Fatheree , Adam A Goldblum , Lan Jiang , Daniel D Long , Daniel Marquess , S. Derek Turner
发明人: Seok-Ki Choi , Paul Fatheree , Adam A Goldblum , Lan Jiang , Daniel D Long , Daniel Marquess , S. Derek Turner
IPC分类号: C07D215/00
CPC分类号: C07D451/04
摘要: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供新颖的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT 4受体活性有关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号:US07534889B2
公开(公告)日:2009-05-19
申请号:US12136891
申请日:2008-06-11
申请人: Seok-Ki Choi , Paul Fatheree , Adam A Goldblum , Lan Jiang , Daniel D Long , Daniel Marquess , S. Derek Turner
发明人: Seok-Ki Choi , Paul Fatheree , Adam A Goldblum , Lan Jiang , Daniel D Long , Daniel Marquess , S. Derek Turner
IPC分类号: C07D215/00 , A01N43/90
CPC分类号: C07D451/04
摘要: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供新的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT4受体活性有关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号:US20080255187A1
公开(公告)日:2008-10-16
申请号:US12136891
申请日:2008-06-11
申请人: Seok-Ki Choi , Paul Fatheree , Adam A. Goldblum , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
发明人: Seok-Ki Choi , Paul Fatheree , Adam A. Goldblum , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
IPC分类号: A61K31/439 , A61P1/00
CPC分类号: C07D451/04
摘要: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供新颖的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT 4受体活性有关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号:US07419989B2
公开(公告)日:2008-09-02
申请号:US11314591
申请日:2005-12-21
申请人: Paul Fatheree , Roland Gendron , Adam A Goldblum , Daniel D Long , Daniel Marquess , S. Derek Turner , Seok-Ki Choi
发明人: Paul Fatheree , Roland Gendron , Adam A Goldblum , Daniel D Long , Daniel Marquess , S. Derek Turner , Seok-Ki Choi
IPC分类号: C07D401/14
CPC分类号: C07D451/04
摘要: The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供了新的吲唑 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT 4受体活性有关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号:US07786136B2
公开(公告)日:2010-08-31
申请号:US12008840
申请日:2008-01-15
申请人: Paul Fatheree , Roland Gendron , Adam A Goldblum , Daniel D Long , Daniel Marquess , S. Derek Turner , Seok-Ki Choi
发明人: Paul Fatheree , Roland Gendron , Adam A Goldblum , Daniel D Long , Daniel Marquess , S. Derek Turner , Seok-Ki Choi
IPC分类号: A61K31/46
CPC分类号: C07D451/04
摘要: The invention provides novel indazole-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供了新的吲唑 - 甲酰胺5-HT4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT4受体活性有关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号:US07875629B2
公开(公告)日:2011-01-25
申请号:US12234906
申请日:2008-09-22
申请人: Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
发明人: Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
IPC分类号: A61K31/46
CPC分类号: C07D451/04 , C07D453/02
摘要: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供新的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT4受体活性有关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号:US20090036483A1
公开(公告)日:2009-02-05
申请号:US12234906
申请日:2008-09-22
申请人: Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
发明人: Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
IPC分类号: A61K31/46
CPC分类号: C07D451/04 , C07D453/02
摘要: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供新的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT4受体活性有关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
公开(公告)号:US07446114B2
公开(公告)日:2008-11-04
申请号:US11365320
申请日:2006-03-01
申请人: Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
发明人: Adam A. Goldblum , Seok-ki Choi , Paul R. Fatheree , Roland Gendron , Lan Jiang , Daniel D. Long , Daniel Marquess , S. Derek Turner
IPC分类号: A01N43/42 , A61K31/44 , C07D401/00 , C07D405/00 , C07D409/00 , C07D411/00 , C07D413/00 , C07D417/00 , C07D419/00 , C07D421/00 , C07D451/00
CPC分类号: C07D451/04 , C07D453/02
摘要: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供新颖的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT 4受体活性有关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
9.
公开(公告)号:US20140163063A1
公开(公告)日:2014-06-12
申请号:US14043585
申请日:2013-10-01
申请人: Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
发明人: Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
IPC分类号: C07D451/02
CPC分类号: C07D451/02 , C07D451/04
摘要: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供新的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT4受体活性有关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
10.
公开(公告)号:US20080176895A1
公开(公告)日:2008-07-24
申请号:US12075669
申请日:2008-03-13
申请人: Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
发明人: Daniel Marquess , Paul R. Fatheree , S. Derek Turner , Daniel D. Long , Seok-Ki Choi , Adam A. Goldblum , Daniel Genov
CPC分类号: C07D451/02 , C07D451/04
摘要: The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
摘要翻译: 本发明提供新颖的喹啉酮 - 甲酰胺5-HT 4受体激动剂化合物。 本发明还提供包含这些化合物的药物组合物,使用这些化合物治疗与5-HT 4受体活性相关的疾病的方法,以及可用于制备这些化合物的方法和中间体。
-
-
-
-
-
-
-
-
-